These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28085213)

  • 1. Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta-analysis.
    Si T; Chen Y; Ma D; Gong X; Guan R; Shen B; Peng C
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1286-1294. PubMed ID: 28085213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials.
    Si T; Chen Y; Ma D; Gong X; Yang K; Guan R; Peng C
    Scand J Gastroenterol; 2016 Dec; 51(12):1512-1519. PubMed ID: 27598831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
    Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
    J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
    Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
    J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
    Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
    World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
    Lv XH; Wang CH; Xie Y
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1540-1547. PubMed ID: 28299819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Transarterial Chemoembolization Improves Survival After Liver Transplant in Patients With Hepatocellular Carcinoma.
    Werner JD; Frangakis C; Ruck JM; Hong K; Philosophe B; Cameron AM; Saberi B; Gurakar A; Georgiades C
    Exp Clin Transplant; 2019 Oct; 17(5):638-643. PubMed ID: 30251938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
    Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
    Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
    Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
    World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Preoperative Transarterial Chemoembolization for Hepatocellular Carcinoma Increase the Incidence of Hepatic Artery Thrombosis After Living-Donor Liver Transplant?
    Ince V; Ersan V; Karakas S; Kutluturk K; Karadag N; Kutlu R; Yilmaz S
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):21-24. PubMed ID: 28301994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis.
    Li L; Li B; Zhang M
    Acta Radiol; 2020 Jun; 61(6):723-731. PubMed ID: 31594382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
    Millonig G; Graziadei IW; Freund MC; Jaschke W; Stadlmann S; Ladurner R; Margreiter R; Vogel W
    Liver Transpl; 2007 Feb; 13(2):272-9. PubMed ID: 17256758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma.
    Kim HD; An J; Kim JH; Gwon DI; Shin JH; Ko GY; Yoon HK; Sung KB; Kim KM; Lee HC
    J Vasc Interv Radiol; 2016 Apr; 27(4):504-13. PubMed ID: 26896049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
    Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN
    J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Huang K; Zhou Q; Wang R; Cheng D; Ma Y
    J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhu ZX; Wang XX; Yuan KF; Huang JW; Zeng Y
    HPB (Oxford); 2018 Sep; 20(9):795-802. PubMed ID: 29779970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?
    Kohi MP; Fidelman N; Naeger DM; LaBerge JM; Gordon RL; Kerlan RK
    J Vasc Interv Radiol; 2013 Jan; 24(1):68-73. PubMed ID: 23176968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.